Efforts to control drug-resistant TB outbreaks failing, say experts

12 November 2007

Current approaches to diagnosing and treating tuberculosis are ineffective and do not reach the majority of people with drug-resistant TB, particularly in regions with high HIV rates, according to public health advocates meeting in Cape Town, South Africa, for the annual World Conference on Lung Health.

The advocates, including the Open Society Institute, Treatment Action Campaign, AIDS & Rights Alliance for Southern Africa, Partners In Health and Medecins Sans Frontieres, are convening a meeting on November 9 with global leaders on TB control to explore community-based solutions to stem the spread of multidrug-resistant tuberculosis and to encourage patients to take their full course of antibiotics.

"TB is a treatable disease but for far too many people it has become a death sentence," said George Soros, chairman of the OSI, adding that "global leaders should use this week's World Conference on Lung Health to move away from empty rhetoric and commit to real programs that can save countless lives."

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK







Today's issue

Company Spotlight